BioNTech SE (BNTX) Payables (2018 - 2024)
BioNTech SE's Payables history spans 7 years, with the latest figure at $456.0 million for Q4 2024.
- For Q4 2024, Payables rose 19.71% year-over-year to $456.0 million; the TTM value through Dec 2024 reached $456.0 million, up 19.71%, while the annual FY2024 figure was $461.8 million, 20.61% up from the prior year.
- Payables for Q4 2024 was $456.0 million at BioNTech SE, up from $380.9 million in the prior quarter.
- Across five years, Payables topped out at $456.0 million in Q4 2024 and bottomed at $132.8 million in Q4 2020.
- The 5-year median for Payables is $331.6 million (2021), against an average of $301.9 million.
- The largest annual shift saw Payables skyrocketed 365.01% in 2020 before it plummeted 37.21% in 2022.
- A 5-year view of Payables shows it stood at $132.8 million in 2020, then surged by 149.69% to $331.6 million in 2021, then tumbled by 37.21% to $208.2 million in 2022, then soared by 82.91% to $380.9 million in 2023, then increased by 19.71% to $456.0 million in 2024.
- Per Business Quant, the three most recent readings for BNTX's Payables are $456.0 million (Q4 2024), $380.9 million (Q4 2023), and $208.2 million (Q4 2022).